Mutations in the WNK1 gene cause Gordon's syndrome, a rare Mendelian form of hypertension. We assessed whether common WNK1 variants might also contribute to essential hypertension, a multifactorial disorder affecting over 25% of the adult population worldwide. A panel of 19 SNPs spanning the gene were selected from public databases and were genotyped in 100 white European families to determine the pattern of linkage disequilibrium, haplotype structure and tagging SNPs for the PRKWNK1 locus. Eight tagging SNPs were identified with 90% power to predict common WNK1 haplotypes and SNPs.
INTRODUCTION
Essential Hypertension (EH; MIM 145500) is a major public health problem, affecting over 25% of the adult population worldwide, and it contributes to morbidity and mortality from stroke, myocardial infarction, end-stage renal disease and congestive heart failure (1, 2) . It is a complex disorder, where multiple genetic and environmental factors interact to produce the final phenotype, and evidence from both family and epidemiological studies suggest that 30-50% of blood pressure (BP) variation within a population is genetic in origin (3) . With the exception of rare Mendelian forms of hypertension, no single gene has been found to have a major affect on BP variation or hypertension as an outcome (4, 5) . The discovery of the genes responsible for these rare diseases has however highlighted new genes and pathways as candidates for EH.
Pseudohypoaldosteronism type II (PHAII; MIM 145260), or Gordon's syndrome, is a rare Mendelian disorder featuring hypertension, hyperkalemia, hyperchloraemia, and metabolic acidosis (6) (7) (8) . The clinical features of PHAII are chloride dependent and can be corrected with thiazide diuretics, a family of drugs often used to treat patients with EH that act by inhibiting sodium chloride (Na (10) (11) (12) . The WNK1 disease causing mutations are large deletions in the first intron (21kb and 42kb) that increase gene expression and correlate with BP levels (12) . The exact mechanism by which these mutations increase WNK1 expression is unknown. In some PHAII patients carrying the WNK1 deletion mutations, hypertension develops following a time course that mimics the onset of EH, raising the possibility that mutations in WNK1 could also contribute to hypertension in the general population (13) .
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WNK1 is predominantly expressed in the distal nephron of the kidney at sites involved in regulating Na + Cl -reabsorption, and studies suggest that increased WNK1 expression, as seen in PHAII patients, would have the net result of increasing Na + reabsorption leading to volume expansion induced hypertension (14) (15) (16) (17) (18) (19) (20) . Indeed, a number of studies have implicated the kidney and disturbances in sodium homeostasis in the aetiology of EH (4, 21, 22) . Thus WNK1 is an obvious candidate for EH. One study has so far assessed the role of WNK1 in EH. In a population based association analysis, Kokubo et. al. (23) failed to detect association with EH or BP variation in a large Japanese population (771 subjects with hypertension and 1,047 controls). To date, however, no study has investigated the association of common WNK1 variants or their haplotypes with EH and BP variation in a Caucasian population.
PRKWNK1 maps to chromosome 12p13.3, is encoded by 28 exons and spans over 150kb of genomic DNA (12) . Over 100 putative WNK1 single nucleotide polymorphisms (SNPs) now exist in the public domain that can be used for association analysis (24). By exploiting the pattern of linkage disequilibrium (LD) within the gene, it is possible to identify disease susceptibility alleles via indirect association analysis using haplotype-based methods (25-27). We employed this strategy in the MRC British Genetics of HyperTension (BRIGHT) study to test for association between variants of WNK1 and EH. A secondary analysis tested for association with severity of hypertension as this correlates with increased cardiovascular risk (28, 29). A panel of 19 SNPs, ~ 1 SNP/10kb, spanning the length of the PRKWNK1 genomic region were selected from dbSNP and genotyped in 100 white British families to determine the pattern of LD, haplotype structure and 'tagging SNPs' (tSNPs) for the
RESULTS

The BRIGHT study TDT resource
As part of the MRC BRIGHT study a large repository of 712 severely hypertensive families has been established that will allow transmission disequilibrium testing for fine mapping and candidate gene studies. As far as we are aware this resource represents the largest white European hypertensive TDT population in the world. These families consist of 371 standard trios, with the remaining 341 comprising of single parent families, with the proband and multiple siblings. The characteristics of the hypertensive probands are presented in Table 1 . Table 2 shows the 19 WNK1 polymorphisms selected for genotyping in this study.
WNK1 polymorphisms
The genomic structure of PRKWNK1 and the relative physical position of the SNPs are presented in Figure 1a . We selected SNPs spaced approximately 1 SNP every 10 Kb from dbSNP, including all non-synonymous coding SNPs (cSNPs) and SNPs immediately 5' and 3' of the PRKWNK1 locus. Only three cSNPs, located in exons 1 (rs3168640), 8 (rs2286007) and 13 (rs956868) were polymorphic in our population. The cSNPs lie outside of any functionally important domains (see Figure 1a) ; the kinase domain is encoded by exons 1-6, the autoinhibitory domain lies within a highly conserved stretch of residues encoded by exons 6-7 and the coiled-coiled domains are encoded by exons 7-8 and 24-25 (10-12, 34). Two SNPs, one 5' (rs1468326) and one 3' (rs1051669) of PRKWNK1 were validated as candidates for genotyping. No suitable promoter SNPs were identified at the time of the database search.
The 5' SNP rs1468326, however, lies ~3 kb proximal to the PRKWNK1 promoter region (35). We also selected a number of SNPs that span the region of the PHAII causing deletion mutations in intron 1.
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Our goal was not to investigate all of the WNK1 sequence variation, but to generate a set of informative markers that were relatively evenly spaced throughout the gene. The average intermarker distance was ~9kb, with the smallest and largest gaps between SNPs being 1.6kb and 18.4kb respectively. For all assayed SNPs, no significant departure from Hardy-Weinberg equilibrium was found.
WNK1 linkage disequilibrium
The 19 polymorphisms were genotyped in 100 families from the BRIGHT TDT resource, and the parents' genotypes were used to determine the pattern of LD and haplotype structure for the PRKWNK1 locus. The families consist of 181 unrelated parents, of whom 105 were hypertensive.
A graphical representation of the pairwise LD as measured by Lewontin's |D'| and r 2 is shown in Figure 1b . The SNP rs3168640 (SNP 2) was extremely rare in our population (minor allele frequency, MAF=0.006%) and was therefore excluded from further analysis. WNK1 haplotype structure Figure 1d shows the structure of the 16 WNK1 haplotypes with frequencies >1%. Six common haplotypes with frequencies greater than 5% were observed and account for 75% of all haplotypes in our population, with the most common haplotype being present in ~20% of the population. In total, 37 unique haplotypes were identified (data not shown), 16 of which account for >90% of all chromosomes in the population (see Figure 1d ).
WNK1 tagging SNPs
As there is significant LD operating over the entire genomic region of WNK1 and as there is currently no consensus on how to define haplotype blocks or their boundaries, we treated the PRKWNK1 locus as a single block for tSNP selection. We found a subset of 8 tSNPs that had >90% power to predict common WNK1 haplotypes and the remaining SNPs from the larger panel of markers (minimum R h 2 = 100%; R s 2 = 94%). The 8 tSNPs are indicated in Table 2 along with the associated coefficients of determination R s 2 for the untyped SNPs.
TDT analysis
No statistically significant association was found between EH and any of the tSNPs individually. The strongest support for association, although not statistically significant, was found with the 5' SNP rs1468326 (Z=+1.499, P=0.134) with allele 'C' being over-transmitted in our population ( (Figure 1d ). The strongest support for over transmission in our population was obtained for the common tSNP haplotype 'CACCCCCG' ( (Figure 1d ).
Quantitative TDT analysis
Data in humans and animal models suggest that WNK1 expression may be directly correlated with BP levels (12, 36 Quantitative analysis revealed significant association between the 5' tSNP rs1468326 with severity of hypertension for both SBP and DBP (Table 3 , SBP: Z=+2.241, P=0.025; DBP Z=+1.992, P= 0.046). Allele 'C' of rs1468326 is over-transmitted in our hypertensive population and is positively associated with both SBP and DBP.
Haplotype analysis found significant association of the apparently protective haplotype h10, 'AGCCTCCG', with SBP and DBP ( was also negatively associated with EH. When allele 'A' of rs1468326 is replaced by allele 'C' (haplotype h6: 'CGCCTCCG'), there is no evidence of association with EH or BP variation (P >0.6).
Haplotype analysis also reveals nominal positive association between SBP and the tSNP haplotype 'CACCCCCG' (Table 4; 
DISCUSSION
We tested for association between eight WNK1 tSNPs and their haplotypes with EH and severity of hypertension, in a large family based Caucasian hypertensive resource from the U.K. We postulated that in any large hypertensive population there will be variation in the severity of hypertension, therefore, quantitative analysis in such a selected population might also identify genetic variants that contribute to severity of hypertension. We found no association of WNK1 with EH, but observed suggestive evidence for association between variants of WNK1 and severity of hypertension. The estimated GRR of 1.24(95 % CI 0.94-1.64) for the associated 5' SNP (rs1468326) and GRR 1.21(95% CI 0.91-1.62) for haplotype h4 suggests WNK1 may not represent a major gene for EH. Our data is nominally significant and should therefore be treated with caution until replication; however, we believe that the data presented here warrants further investigation of WNK1 and its potential role in EH and BP regulation. The associated SNP lies approximately 3kb proximal to the WNK1 promoter region (35) and displays little LD with any of the intragenic markers that were studied. Given its position, however, it is feasible that this 5' SNP could be in LD with functional promoter variants that could alter WNK1 expression and therefore affect BP. Although our haplotype tagging approach is likely to have captured most of the common WNK1 variation, it is possible that some variants were not represented by the tSNPs and haplotypes studied, especially within the WNK1 regulatory regions and functional domains. Currently, there are no validated WNK1 promoter SNPs in the public databases. The identification of promoter SNPs will greatly facilitate further investigation of WNK1 in EH and BP variation.
Increased WNK1 expression causes PHAII in humans and decreased levels of expression in heterozygous knockout mice lead to decreased BP (12, 36) . This suggests that any functional variant which alters WNK1 expression will have an effect on BP; although, we would expect the magnitude of variation to be less than that observed in mice lacking one copy of the gene (~12mmHg). It is likely that common functional WNK1 variants will not affect human BP levels by more than a few mmHg. However, there is evidence from epidemiological studies that an increase in BP by a few mmHg, for example as a result of particular genetic variant, could significantly enhance the risk of target organ damage, especially when combined with the added affects from other genes and environmental factors (29, 37). This is particularly relevant in the context of EH as a complex disease, where mounting evidence suggests that multiple genes with modest or minor influences on BP levels may contribute to disease susceptibility (38-40).
The results presented here have not been corrected for multiple testing. The common strategy of Bonferroni correction is overly conservative, even when the tests are independent Under this framework, a p value of around 10 -4 is appropriate for a candidate gene for which the prior odds of association are about 1,000:1. We do not achieve this level of significance.
However, in light of WNK1 function and data from animal models, we could argue for larger prior odds of association, and hence declare significance, but we resist this temptation.
Similarly, if we use the approximation suggested by Nyholt et. al. (47) , a solution to the problem of non-independence due to LD, our results are non-significant. Instead we view these results as suggestive evidence for association and acknowledge that further work will be needed to confirm the results of this study.
In summary, we have conducted the first haplotype tagging analysis of the WNK1 gene with EH and BP phenotypes. We have found nominally significant association which appears to depend on a 5' SNP proximal to the WNK1 promoter. The data presented here supports the hypothesis that common WNK1 variants could contribute to BP variation and increase susceptibility to human EH. However, further analysis in other populations as well as functional studies will be required to elucidate the role of these variants in BP variation and susceptibility to EH.
MATERIAL AND METHODS
Study Population
As part of the MRC BRIGHT study (http://www.brightstudy.ac.uk), over 800
hypertensive families of white European ancestry have been recruited to allow transmission disequilibrium testing (48) . Family ascertainment and phenotyping were performed as institutes, and all participants gave informed written consent. DNA was extracted from whole blood using a modified salting-out method (49). After phenotyping and paternity checks, 88
families were excluded from the study. In total, 712 families were included in the present analysis. These families consist of one or more severely hypertensive offspring of white European ancestry up to the level of grandparents, in whom hypertension was diagnosed before the age of 60 years, and other family members usually both parents, or a single parent and other siblings.
SNP identification
In order to identify a set of SNPs for haplotype association analysis we searched public databases using the SNP search tool available at the Institute of Human Genetics, 
Genotyping
All genotyping was performed using the Taqman assay developed by Applied Biosystems, followed by allelic discrimination using the ABI PRISM 7900HT Sequence Detection System and software (SDSv2.0, Applied Biosystems) (50, 51). Specific WNK1 SNP Taqman probes and primers were obtained from Applied Biosystems Assay-byDesign™ Service for SNP Genotyping (available on request). The average rate of success for each genotyped SNP was 98%. We tested for any Mendelian inconsistencies/genotyping errors using the program PEDCHECK (52). All genotyping errors were manually resolved by checking raw genotype data, individuals were either blanked (zeroed) or corrected prior to analysis.
LD analysis, haplotype estimation and tSNP selection
To estimate the pattern of LD, haplotype structure and to determine the tagging SNPs, we genotyped 19 WNK1 SNPs in a subset of the TDT population (n=100 families). The parental haplotype data were used to explore the pattern of LD within the gene. The proband's genotypes were used to help resolve phase and identify major haplotype missassignments in the parents that are detected as Mendelian inconsistencies using PEDCHECK (52). Hardy-Weinberg equilibrium was assessed by the Chi square test with one degree of freedom in all parents (n=181). LD between SNPs was estimated using the program ldmax (53), and visualised using displd (available at C. Wallace's web site, http://www.qmul.ac.uk/~hhw159/perlprogs/). Lewontin's |D'| and the correlation coefficient r 2 were used as a measures of LD between SNPs (54-56). To assess the relationship between |D'| and r 2 with distance, Spearman's correlation coefficient rho (ρ) was calculated using SPSS v12 software (SPSS, Chicago, USA). WNK1 haplotypes and their estimated frequencies were defined using the program PHASE v2.1 (57). Haplotype structure and frequencies are reported for the parents only.
For tSNP selection, parental haplotypes were determined using the EM algorithm, haplotypes.
Statistical Analysis
The TDT proposed by Spielman et. al. (48) Age and sex were included as covariates for the analyses of quantitative traits and an additive genetic model was assumed throughout, as this model performs well across a range of possible genetic models (65, 66) . P values were computed using 100,000 Monte-Carlo permutations and are presented together with the normalized statistic Z=S/Var(S). We use the term 'positive association' to describe the situation where the Z statistic is positive and statistically significant, and 'negative association' when Z is negative and statistically significant (this is different from 'no association'). We have used a threshold of p<0.05 to infer statistical significance. Genotype relative risks (GRR) were estimated from the TDT analysis using the methods proposed by Kazeem and Farrall (in press, 67) .
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